Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab in uncontrolled asthma
NCT01545453Phase 2Completed
- Sponsor
- Genentech
- Start
- Mar 2012
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of lebrikizumab in asthma, sponsored by Genentech. Started Mar 2012; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01545453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545453.